Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Næsby Kiropraktik og Fysioterapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.7% 3.7% 4.0% 6.8% 9.1% 6.8% 19.6% 19.6%   Credit score (0-100)   37 53 50 34 26 34 6 6   Credit rating   BBB BBB BBB BBB BB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,856 5,094 5,780 6,778 6,771 7,009 0.0 0.0   EBITDA   793 657 653 551 485 686 0.0 0.0   EBIT   661 420 350 113 40.9 217 0.0 0.0   Pre-tax profit (PTP)   643.6 392.8 323.4 90.4 2.5 152.9 0.0 0.0   Net earnings   500.9 306.7 257.8 99.5 6.2 119.3 0.0 0.0   Pre-tax profit without non-rec. items   644 393 323 90.4 2.5 153 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   970 1,051 1,079 1,458 1,234 833 0.0 0.0   Shareholders equity total   851 837 795 645 551 670 195 195   Interest-bearing liabilities   981 780 581 944 1,426 1,381 0.0 0.0   Balance sheet total (assets)   2,290 2,055 2,078 2,744 2,511 2,429 195 195   Net Debt   638 751 443 768 1,319 1,148 -195 -195     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,856 5,094 5,780 6,778 6,771 7,009 0.0 0.0   Gross profit growth   50.3% 4.9% 13.5% 17.3% -0.1% 3.5% -100.0% 0.0%   Employees   0 0 0 0 0 12 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,290 2,055 2,078 2,744 2,511 2,429 195 195   Balance sheet change%   109.6% -10.3% 1.1% 32.1% -8.5% -3.3% -92.0% 0.0%   Added value   793.3 657.5 653.2 550.8 478.3 686.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   480 -157 -274 -58 -669 -871 -833 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.6% 8.2% 6.1% 1.7% 0.6% 3.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   39.1% 19.3% 17.0% 4.7% 1.6% 8.8% 0.0% 0.0%   ROI %   48.8% 23.7% 22.7% 7.5% 2.3% 10.7% 0.0% 0.0%   ROE %   80.8% 36.3% 31.6% 13.8% 1.0% 19.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   37.1% 40.8% 38.3% 23.5% 21.9% 27.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   80.5% 114.2% 67.9% 139.5% 271.8% 167.4% 0.0% 0.0%   Gearing %   115.3% 93.2% 73.0% 146.5% 258.9% 206.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.4% 3.0% 3.9% 3.0% 3.2% 4.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 0.8 0.8 0.6 0.7 0.9 0.0 0.0   Current Ratio   0.9 0.9 0.8 0.6 0.8 0.9 0.0 0.0   Cash and cash equivalent   342.0 29.6 137.3 175.8 107.5 232.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -81.8 -161.3 -239.0 -793.4 -299.0 -73.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 57 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 57 0 0   EBIT / employee   0 0 0 0 0 18 0 0   Net earnings / employee   0 0 0 0 0 10 0 0